Company Overview and News

 
Globe, Disney wrap up Time Please with 22.1 million volunteering hours

2018-10-12 business.inquirer.net
Time Please winners John Mark Panares (2nd from left) and Jade Mabalos (middle) with Seshasaye Kanthamraju, Executive Director for Communications & Citizenship, The Walt Disney Company Southeast Asia (left), Miguel Bermundo, Director of Globe Citizenship and Advocacy Marketing (2nd from right) and JB Tan, Founder and Executive Director of iVolunteer Philippines (right).
GLO MWC GTMEY AYAAY GTMEF GLOPP GLOPA ALI AYAAF

 
Dumaguete water firm hit for ‘malicious’ claims

2018-10-06 newsinfo.inquirer.net
DUMAGUETE CITY — The head of the city’s lone water distributor cried foul over what he said was a “malicious” accusation that the Dumaguete City Water District (DCWD) blocked a joint venture deal with a company to favor another.
MWC

 
DPWH to conduct roadworks over weekend

2018-10-05 newsinfo.inquirer.net
The Department of Public Works and Highways (DPWH) will conduct road repairs and reblocking in some areas starting 11 p.m. Friday, October 5, until 5 a.m. on Monday, October 8.
MWC

 
Manila Water to start first part of rate hike on October 16

2018-10-01 newsinfo.inquirer.net
Manila Water Company Inc. said on Monday that it will start implementing the first tranche of its approved rate hike on October 16 of this year.
MWC

 
Manila Water rates up starting October

2018-09-28 business.inquirer.net
Residential customers of Manila Water Co. Inc. will pay more each month starting October by at least P5.68 per cubic meter as regulators approved an increase in the company’s basic charge.
MWC

 
MWSS evaluating options if water concessionaires win SC case

2018-09-28 bworldonline
THE Metropolitan Waterworks and Sewerage System (MWSS) is evaluating its options, including returning to negotiations, should the Supreme Court (SC) decide in favor of Metro Manila’s two water concessionaires that their corporate income tax (CIT) is an expense that can be passed on to consumers.
MWC

 
Maynilad wins P5.73/cu.m. tariff hike

2018-09-14 bworldonline
MAYNILAD Water Services, Inc. has obtained an increase of P5.73 per cubic meter (cu. m.) in water tariffs for Metro Manila’s west zone, which the company is offering to impose on a staggered basis.
DMC MWC MPCFF MPCIY MPI DMCIF DMCHY DMCP

 
Maynilad wins tariff hike of P5.73 per cubic meter

2018-09-14 bworldonline
MAYNILAD Water Services, Inc. has obtained an increase of P5.73 per cubic meter (cu. m.) in water tariffs for Metro Manila’s west zone, which the company is offering to impose on a staggered basis.
DMC MWC MPCFF MPCIY MPI DMCIF DMCHY DMCP

 
Fears of water shortage in metro allayed

2018-08-31 newsinfo.inquirer.net
Top officials of the Metropolitan Waterworks and Sewerage System (MWSS) have reassured the public of adequate supply of potable water in the coming years amid reports that Metro Manila might experience water shortage in 2021 before the end of President Duterte’s term.
MWC

 
MWSS pushing for new dam projects

2018-08-31 business.inquirer.net
The Metropolitan Waterworks and Sewerage Systems favors new dam projects instead of ones that tap the Laguna de Bay for the production of potable water, according to MWSS administrator Reynaldo V. Velasco.
MWC

 
MWSS downplays fears of water shortage in 2021

2018-08-31 bworldonline
Metropolitan Waterworks and Sewerage System (MWSS) has downplayed the alarm sounded off by one of its water concessionaire that the Philippine capital is likely to experience water shortage if alternative sources are not built in the next three years.
MWC

 
Water shortage seen by 2021 without Laguna Lake project

2018-08-29 bworldonline
MANILA WATER Co., Inc. has raised the alarm over a possible water shortage starting in 2021 if it fails to get approval for the construction of a new water source from Laguna Lake ahead of the target completion of the Kaliwa dam in Quezon province by 2023.
MWC

 
Manila Water warns of water shortage between 2021 and 2023

2018-08-29 bworldonline
Manila Water Co., Inc. has raised the alarm over a possible water shortage starting in 2021 if it fails to get approval for the construction of a new water source from Laguna Lake ahead of the target completion of the Kaliwa dam in Quezon province by 2023.
MWC

 
Manila Water inks deal with water district in Bulacan

2018-08-16 bworldonline
THE CONSORTIUM of Manila Water Co., Inc. and its subsidiary has signed a joint venture agreement with a water district in Bulacan to handle the latter’s water supply system and sanitation facilities, the Ayala-led company told the stock exchange on Thursday.
MWC

 
Water service interruptions announced

2018-08-14 bworldonline
MAYNILAD WATER Services, Inc. will reduce water production because of the increase in turbidity at Ipo Dam resulting in increased sediment concentrations in the raw water it distributes, Metro Manila’s west zone concessionaire said on Tuesday.
MWC

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...